Technology NetworksCRISPR Study Reveals Errors in Earlier Cancer ResearchTechnology NetworksCRISPR Study Reveals Errors in Earlier Cancer Research. News Feb 23, 2018 | Original Story by Chris Palmer for Cold Spring Harbor Laboratory. CRISPR Study Revea… Continue reading
Technology NetworksCRISPR Study Reveals Errors in Earlier Cancer ResearchTechnology NetworksCRISPR Study Reveals Errors in Earlier Cancer Research. News Feb 23, 2018 | Original Story by Chris Palmer for Cold Spring Harbor Laboratory. CRISPR Study Revea… Continue reading
Technology NetworksCRISPR Study Reveals Errors in Earlier Cancer ResearchTechnology NetworksThe growth of human colon cancer cells (raised in culture) is unaffected by presence or absence of MELK. Top row: untreated cells; bottom row: cells treated wit… Continue reading
Wired.co.ukGene-modification is the next frontier in the fight against cancerWired.co.ukWhen the results came in, they revealed that the single dose of infusion therapy had eradicated the leukemia in two patients, destroying kilograms of cancer cells. … Continue reading
China.org.cn |
China Focus: Chinese scientists regenerate lung with stem cells
Xinhua SHANGHAI, Feb. 23 (Xinhua) — Chinese scientists are celebrating a breakthrough in the treatment of lung disease that enables patients with damaged respiratory organs to breathe normally. Regenerative medicine specialists at Tongji University and … World’s first autologous lung stem cell transplant conducted in ChinaChina.org.cn |
PharmaTimes |
Gilead links with Sangamo in gene therapy alliance
PharmaTimes Gilead’s Kite is linking with Sangamo Therapeutics in a collaboration that aims to develop next-generation engineered cell therapies for the treatment of cancer. Kite will use Sangamo’s ZFN technology gene therapies for autologous and allogeneic use in … Kite, Sangamo Launch Up-to-$3B+ Cancer Cell Therapy PartnershipGenetic Engineering & Biotechnology News Sangamo in $3 billion gene-editing deal with GileadReuters Kite and Sangamo come together in $3bn cancer gene editing alliancepharmaphorum |